Papers (English)

Original papers

1. Hamaguchi T, Iwasa K, Okino S, Yamada M. Carotid duplex ultrasonography during head-up tilt in patients with orthostatic hypotension. Eur Neurol 57:219-222, 2007

2. Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, Sato T, Kitamoto T, Mizusawa T, Yamada M. Ophthalmic surgery in prion diseases. Emer Inf Dis 13:162-164, 2007

3. Hamaguchi T, Sakajiri K, Sakai K, Okino S, Sada M, Kusunoki S. Guillain-Barré syndrome with antibodies to GD1a/ GD1b complex. J Neurol Neurosurg Psychiatry 78: 548-549, 2007

4. Hirohata M*, Hasegawa K*, Tsutsumi-Yasuhara S, Ohhashi Y, Ookoshi T, Ono K, Yamada M, Naiki H. The Anti-amyloidogenic effect again Alzheimer's β-amyloid fibrils in vitro is exerted by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 46:1888-1899, 2007. *equally contributed authors

5. Inaki N, Kanehira E, Kinoshita T, Komai K, Omura K, Watanabe G. Ringed silicon rubber attachment prevents laparoscopic surgeon's thumb. Surg Endosc 21:1126-1130, 2007

6. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC, Kranwinkel G, Sacco RL, DeCarli C. Chronic kidney disease is associated with white matter hyperintensity volume: The Northern Manhattan Study (NOMAS). Stroke 38:3121-3126, 2007

7. Machiya T, Yoshita M, Iwasa K, Yamada M. Primary spinal intramedullary lymphoma mimicking ependymoma. Neurology 68:872, 2007

8. Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M. Blood-brain barrier permeability correlates with medial temporal lobe atrophy, but not with amyloid-β protein transport across the blood-brain barrier in Alzheimer's disease. Dement Geriatr Cogn Disord 23:241-245, 2007

9. Matsunari I, Samuraki M, Chen WP, Yanase D, Takeda N, Ono K, Yoshita M, Matsuda H, Yamada M, Kinuya S. Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance. J Nucl Med 48:1961-1970, 2007

10. Morinaga A, Hirohata M, Ono K, Yamada M. Estrogen has anti-amyloidogenic effects on Alzheimer's β-amyloid fibrils in vitro. Biochem Biophys Res Commun 359:697-702, 2007

11. Morinaga A, Ono K, Komai K, Yamada M. Microscopic polyangitis presenting with temporal arteritis and multiple cranial neuropathies. J Neurol Sci 256:81-83, 2007

12. Motozaki Y, Komai K, Hirohata M, Asaka T, Ono K, Yamada M. Hereditary inclusion body myopathy with a novel mutation in the GNE gene associated with proximal leg weakness and necrotizing myopathy. Eur J Neurol 14:e14-e15, 2007

13. Motozaki Y, Sugiyama Y, Ishida C, Komai K, Matsubara S, Yamada M. Phenotypic heterogeneity in a family with FAP due to a TTR Leu58Arg mutation: a clinicopathologic study. J Neurol Sci 260:236-239, 2007

14. Nakamura Y, Watanabe M, Nagoshi K, Yamada M, Mizusawa H. Geographic difference of mortality of Creutzfeldt-Jakob disease in Japan. J Epidemiol 17:19-24, 2007.

15. Nakata M, Kuwabara S, Kawaguchi N, Takahashi H, Misawa S, Kanai K, Tamura N, Sawai S, Motomura M, Shiraishi H, Takamori M, Maruta T, Yoshikawa H, Hattori T. Is excitation-contraction coupling impaired in myasthenia gravis. Clin Neurophysiol 118:1144-1148, 2007

16. Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H,
Yamada M. Clinical features and diagnosis of dura mater graft-associated Creutzfeldt-Jakob disease. Neurology 69:360-367, 2007

17. Nozaki I, Inao G, Yamada M. Donepezil-induced chorea in Alzheimer's disease. J Neurol 254:1752-1753, 2007

18. Nozaki I, Watanabe T, Kawaguchi M, Akatasu H, Tsuneyama K, Yamamoto Y, Ohe K,
Yonekura H, Yamada M, Yamamoto H. Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains. Arch Histol Cytol 70:279-290, 2007

19. Ono K, Hirohata M, Yamada M. Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases. Exp Neurol 205:414-424, 2007

20. Ono K, Hirohata M, Yamada M. Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for α-synuclein fibrils in vitro. J Neurosci Res 85:1547-1557, 2007

21. Ono K, Noguchi-Shinohara M, Yoshita M, Naiki H, Yamada M. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances α-synuclein fibril formation in vitro. Exp Neurol 203:579-583, 2007

22. Ono K, Yamada M. Vitamin A potently destablizes preformed α-synuclein fibrils in in vitro: implications for Lewy body diseases. Neurobiol Dis 25:446-454, 2007

23. Prabhakaran S, Wright CB, Yoshita M, Delapaz R, Brown T, DeCarli C, Sacco RL. Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology 70:425-430, 2007

24. Sakai K, Matsumoto Y, Nozaki I, Yamada M. Acute autonomic sensory and motor neuropathy associated with central nervous system disturbance. J Clin Neurosci 14:275-278, 2007

25. Samuraki M, Furui E, Komai K, Takamori M, Yamada M. Myasthenia gravis presenting with unusual neurogenic muscle atrophy. Muscle Nerve 36:394-399, 2007

26. Samuraki M, Matsunari I, Chen WP, Yajima K, Yanase D, Fujikawa A, Takeda N, Nishimura S, Matsuda H, Yamada M. Partial Volume Effect Corrected FDG PET and Gray Matter Volume Loss in Patients with Mild Alzheimer's Disease. Eur J Nucl Med Mol Imaging 34:1658-1669, 2007

27. Shibata-Hamaguchi A, Samuraki M, Furui E, Ishida C, Kitagawa S, Nakao S, Minato H,
Yamada M. B-cell neurolymphomatosis confined to the peripheral nervous system. J Neurol Sci 260:249-252, 2007

28. Shibata-Hamaguchi A, Samuraki M, Furui E, Iwasa K, Yoshikawa H, Hayashi S, Yamada. M. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis. Acta Neurol Scand 116:406-408, 2007

29. Shiga Y, Satoh K, Kitamoto T, Kanno S, Nakashima I, Sato S, Fujihara K, Takata H,
Nobukuni K, Kuroda S, Takano H, Umeda Y, Konno H, Nagasato K, Satoh A, Matsuda Y,
Hidaka M, Takahashi H, Sano Y, Kim K, Konishi T, Doh-ura K, Sato T, Sasaki K, Nakamura Y, Yamada M, Mizusawa H, Itoyama Y. Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution. J Neurol 254:1509-1517, 2007

30. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4:675-689, 2007

31. Takamori M, Motomura M, Fukudome T, Yoshikawa H. Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic syndrome. Eur J Neurol 14:1230-1235, 2007

1. Neumann H and Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 182:92-99, 2007

2. Takamori M. Antibodies to presynaptic components acting for synaptic plasticity in myasthenia gravis. Current Topics in Neuroimmunology 265-269, 2007

1. Ono K, Noguchi-Shinohara M, Samuraki M, Matsumoto Y, Yanase D, Iwasa K, Naiki H, Yamada M. Cerebrospinal fluid and plasma of Alzheimer patients promote β-amyloid fibril formation in vitro. In: Skinner M, Berk JL, Connors LH, Seldin DC, ed. XIth International Symposium on Amyloidosis. Boca Raton, Taylor & Francis Group, pp25-26, 2007

Presentations (International meeting)

Invited lectures

1. Ono K. Molecular interactions in the Formation and Destabilization of Alzheimer’s β-amyloid Fibril in vitro. Case Western Reserve University Colloquium Lecture. Cleveland, November 29, 2007

2. Yamada M, Nakamura Y, Akino K. CJD surveillance in Japan. European and Associated Countries Collaborative CJD Surveillance Group, Hameln, Germany, June 7-9, 2007

3. Yamada M. Cerebral Amyloid angiopathy (CAA) and CAA-related Disorders: Epidemiology and Risk Factors. Cerebral Amyloid Angiopathy: Emerging Concepts, Reykjavic, Iceland, August 8-11, 2007

1. Birnbaum L, Wright C, Rundek T, Huang L, Li L, Yoshita M, Schmiedigen A, DeCarli C, Sacco R. Carotid intima media thickness is associated with subclinical infarcts: The NOMAS MRI Substudy. International STROKE conference, San Francisco, Feb 7-9, 2007

2. Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M. Ophthalmic surgery in prion diseases. PRION 2007, Edinburgh, Sep 26-28, 2007

3. Iwasa K, Yoshikawa H, Furukawa Y, T Maruta T, Yamada M. Modified modulating anti-acetylcholine receptor antibodies are the appropriate index of myasthenic crisis. The 11th International Conference on Myasthenia Gravis and Related Disorders, Chicago, May 13-16, 2007

4. Hirohata M, Yoshita M, Ishida C, Ikeda S, Tamaoka A, Kuzuhara S, Shoji M, Ando Y, Tokuda T, Yamada M. A Nationwide Epidemiological Survey CAA-related Disorders in Japan. Cerebral Amyloid Angiopathy: emerging concepts, Iceland, August 8-11, 2007

5. Khatri M, Wright C, Rundek T, Huang L, Yoshita M, Decarli C, Sacco R. Chronic kidney disease is associated with white matter hyperintensity volume: The Northern Manhattan Study. International STROKE conference, San Francisco, Feb 7-9, 2007

6. Shinohara M, Yoshita M, Matsumoto Y, Yamada M. Value of CSF-amyloid beta 1-42, total tau protein, phospholyrated tau protein in the differential diagnosis of DLB from AD: comparison with MIBG radioactivity. International psychogeriatric association, Osaka, October 17-18, 2007

7. Takahashi K, Prinz M, Stagi M, Chechneva O, and Neumann H. Tissue debris clearance by TREM2-transduced myeloid precursors in experimental autoimmune encephalomyelitis. The 11th Congress of the European Federation of Neurological Societies, Brussels, Aug 25-28, 2007

8. Wright CB, Festa JR, Pail MC, Schmiedigen A, Brown TR, Yoshita M, DeCarli C, Stern Y, Sacco RL. White matter hyperintensities and subclinical infarction: Association with psychomotor speed and cognitive flexibility. 132nd American Neurological Association annual meeting, Washington DC, October 7-10, 2007

9. Yamada M. Plaque and Non-plaque Types of Dura Mater Graft-associated Creutzfeldt-Jacob Disease;Clinicopathological and Molecular Analysis. Prion 2007, Scotland UK, Sep 26-28, 2007

10. Yoshita M, Fletcher E, Martinez O, Ortega M, Reed BR, Mungas DM, DeCarli CS. Diffusion tensor imaging of cognitive normal elderly in cerebral white matter: relation to white matter hyperintensities. International STROKE conference, San Francisco, Feb 7-9, 2007

11. Yoshita M, Fletcher E, Ortega M, Martinez O, Carmichael O, Mungas D, Reed B, DeCarli C. White matter hyperintesities and fractional anisotropy are associated with corpus callosum atrophy in Alzheimer disease. 59th American Academy of Neurology annual meeting, Boston, April 28-May 5, 2007